Emerging role of Nrf2 in protecting against hepatic and gastrointestinal disease.
about
Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2.Altered disposition of acetaminophen in Nrf2-null and Keap1-knockdown miceRole of redoximiRs in fibrogenesisRedox-fibrosis: Impact of TGFβ1 on ROS generators, mediators and functional consequencesOxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesisOxidative Stress during HIV Infection: Mechanisms and ConsequencesReactive oxygen species and fibrosis: further evidence of a significant liaisonDiscovery of direct inhibitors of Keap1-Nrf2 protein-protein interaction as potential therapeutic and preventive agentsSmall molecule modulators of Keap1-Nrf2-ARE pathway as potential preventive and therapeutic agentsRegulation of Nrf2-an updateNrf2-dependent induction of NQO1 in mouse aortic endothelial cells overexpressing catalaseBasic principles and emerging concepts in the redox control of transcription factorsThe transcription factor NF-E2-related factor 2 (Nrf2): a protooncogene?Cadmium alters the formation of benzo[a]pyrene DNA adducts in the RPTEC/TERT1 human renal proximal tubule epithelial cell lineComparative transcriptional network modeling of three PPAR-α/γ co-agonists reveals distinct metabolic gene signatures in primary human hepatocytesFeeding of selenium alone or in combination with glucoraphanin differentially affects intestinal and hepatic antioxidant and phase II enzymes in growing rats.Nrf2 deficiency in myeloid cells is not sufficient to protect mice from high-fat diet-induced adipose tissue inflammation and insulin resistance.Dihydro-CDDO-trifluoroethyl amide (dh404), a novel Nrf2 activator, suppresses oxidative stress in cardiomyocytes.Integrated hepatic transcriptome and proteome analysis of mice with high-fat diet-induced nonalcoholic fatty liver diseaseVegetable and fruit juice enhances antioxidant capacity and regulates antioxidant gene expression in rat liver, brain and colon.Impact of Acetazolamide, a Carbonic Anhydrase Inhibitor, on the Development of Intestinal Polyps in Min Mice.Protective effects and functional mechanisms of Lactobacillus gasseri SBT2055 against oxidative stress.Xenobiotic, bile acid, and cholesterol transporters: function and regulation.Nuclear factor erythroid 2-related factor 2 deletion impairs glucose tolerance and exacerbates hyperglycemia in type 1 diabetic mice.Nrf2 upregulates ATP binding cassette transporter expression and activity at the blood-brain and blood-spinal cord barriersLong-term supranutritional supplementation with selenate decreases hyperglycemia and promotes fatty liver degeneration by inducing hyperinsulinemia in diabetic db/db mice.Oxidative stress as a crucial factor in liver diseases.Effects of blueberry on hepatic fibrosis and transcription factor Nrf2 in rats.Hepatocytes lacking thioredoxin reductase 1 have normal replicative potential during development and regeneration.Benzo[a]pyrene increases the Nrf2 content by downregulating the Keap1 message.Hepatitis C virus proteins activate NRF2/ARE pathway by distinct ROS-dependent and independent mechanisms in HUH7 cells.Ginkgo biloba extract induces gene expression changes in xenobiotics metabolism and the Myc-centered networkGene expression profiling in male B6C3F1 mouse livers exposed to kava identifies--changes in drug metabolizing genes and potential mechanisms linked to kava toxicity.Is nuclear factor erythroid 2-related factor 2 responsible for sex differences in susceptibility to acetaminophen-induced hepatotoxicity in mice?Transcriptional regulation of renal cytoprotective genes by Nrf2 and its potential use as a therapeutic target to mitigate cisplatin-induced nephrotoxicity.Diversity in antioxidant response enzymes in progressive stages of human nonalcoholic fatty liver disease.Transcription factor Nrf2 regulates SHP and lipogenic gene expression in hepatic lipid metabolism.Deficiency of interleukin-15 enhances susceptibility to acetaminophen-induced liver injury in mice.Dimethylfumarate attenuates renal fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-β/Smad signalingImpairment of nitrergic system and delayed gastric emptying in low density lipoprotein receptor deficient female mice.
P2860
Q24606271-92D4027A-F4C6-4398-A403-F8310E8D5454Q24652340-4249F0DD-BC72-4FE1-A0BA-CF68C322DE08Q26776555-655C4963-38D4-4CA1-A474-F62FB0BAE88BQ26786129-47D07BA5-2769-4CD9-8B5F-79CE9DB9965EQ28075646-8D2A0C9C-153E-4905-93C2-5B8583977F01Q28077167-B5BA6732-9958-4F45-B72D-AE37066380B3Q28077930-0EE68E9D-344B-48F9-BF45-0A83FC923FBBQ28085561-C3E51823-53B8-4677-863E-96ECB6A5AF68Q28386244-EA32839D-7EE3-4C2A-864B-5B820D13DB4DQ28388589-8A8587D3-DC00-4D05-BEF1-7AEE8E2867A6Q28389107-E3E6B946-C83C-443C-9D1B-156387FD9320Q28391506-4C78DA75-C4D2-46A7-A5B2-40186909F14FQ28393090-582B2390-9782-4A5B-B42E-4F40EE93F613Q28654305-9000183D-021B-4E21-88C1-F764AD065516Q28730590-700B5C97-DEFB-4625-8EE3-FE4FA8937A23Q30317918-C8F0774E-CA24-4F31-B60E-CC19293263A8Q30419533-17663407-4F81-4872-9A73-5B14ADCEE297Q33520215-B5BC188E-316B-48D7-8A64-F4B103B759B5Q33543522-D1D20A0F-01A4-45F9-90C3-E42880C75081Q33617109-2E9B4530-AB01-4EDF-98D4-50FDF7E5033CQ33624857-8186315F-E79B-4426-8EC6-529B3A89C9ABQ33663699-C2C1B8EA-7408-4A9F-A04D-981FF459FD74Q33714593-12B1A4D0-D8D3-4D64-8E43-8218F4DEC67BQ33755271-50C2E1E8-B873-44F1-A3B5-F080DB1C558CQ33770428-3481F29B-9CEC-4CDC-9617-AADFF2C52A7DQ33830906-22C51251-7127-48E8-BF90-E590EE9987F0Q33845484-694F7146-536E-4771-8471-6C7B9D3A1269Q33894212-0680E56E-AA33-4B88-B569-30FADD88247DQ33951227-84E819EB-30D3-47E0-9F97-69271C2D3D21Q34000819-ABD4BCFC-B2CA-4B21-9F11-12C15ACB9D21Q34024112-E10C5DD8-5AA6-4F3B-94B7-C28F650FB805Q34030746-62A25863-4E29-453C-8D17-8376012B741FQ34053019-EC8A5811-9D43-4586-9A51-76D60944E48DQ34186003-34D80940-D54B-449B-A928-1B30CEE2F9F9Q34214639-13559CD4-0195-433B-A8F4-68B63BD03058Q34359482-BEE27698-BBFC-4006-856E-FF1BD61D4A95Q34425926-198B87C0-733D-4A9D-A4AA-2661020907BFQ34427582-6DF739E3-D7FF-425B-B8A0-EDFDEE217C14Q34441024-7B26AF0F-D7E5-4B1B-8874-A87913F03B8BQ35061758-464FE26F-9EA7-4474-8FAE-51428FF7DCD2
P2860
Emerging role of Nrf2 in protecting against hepatic and gastrointestinal disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Emerging role of Nrf2 in protecting against hepatic and gastrointestinal disease.
@en
type
label
Emerging role of Nrf2 in protecting against hepatic and gastrointestinal disease.
@en
prefLabel
Emerging role of Nrf2 in protecting against hepatic and gastrointestinal disease.
@en
P2860
P1476
Emerging role of Nrf2 in protecting against hepatic and gastrointestinal disease.
@en
P2093
José E Manautou
Lauren M Aleksunes
P2860
P304
P356
10.1080/01926230701311344
P407
P577
2007-06-01T00:00:00Z